%PDF-1.4
%
63 0 obj
<>
endobj
60 0 obj
<>
endobj
121 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-12-03T10:52:15Z
2024-03-28T22:16:36-07:00
QuarkXPressª: AdobePS 8.6 (219)
2024-03-28T22:16:36-07:00
application/pdf
Heather
2001-433march02
uuid:73593ca0-1dd2-11b2-0a00-a20927fd5800
uuid:73593ca4-1dd2-11b2-0a00-6a0000000000
endstream
endobj
49 0 obj
<>
endobj
50 0 obj
<>
endobj
64 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
9 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
17 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
20 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
23 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
26 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
29 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
32 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
155 0 obj
[159 0 R]
endobj
156 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
/CS0 CS 0 0 0 1 SCN
/GS1 gs
54 54 m
558 54 l
S
BT
/CS0 cs 0 0 0 1 scn
/TT0 1 Tf
0.02499 Tw 8 0 0 8 424.3613 35.9844 Tm
(The Journal of Rheumatology 2002; 29:2)Tj
0 Tw -46.2952 -0.0313 Td
(254)Tj
ET
0 0 0 0 scn
/GS0 gs
103.25 58.75 407.5 -10.83 re
f*
0.5 w
103.25 58.75 407.5 -10.83 re
S
BT
0 0 0 1 scn
/GS1 gs
/TT1 1 Tf
0.0249 Tw 8 0 0 8 57 714.5293 Tm
[(22.)-875 (Linos )54.8 (A, )17.7 (W)79.8 (orthington JW)91.8 (, O\222Fallon )17.7 (WM, Kurland L)91.8 (T)74 (. )17.7 (The)]TJ
2.175 -1.25 Td
[(epidemiology of rheumatoid arthritis in Rochester)39.8 (, Minnesota: a)]TJ
0 -1.25 TD
[(study of incidence, prevalence, and mortality)64.9 (. )54.9 (Am J Epidemiol)]TJ
0 Tw T*
[(1980;1)36.9 (1)36.9 (1:87-98.)]TJ
0.0249 Tw -2.175 -1.25 Td
[(23.)-875 (Chan KW)91.8 (, Felson DT)74 (, )36.8 (Y)100.1 (ood RA, )17.7 (W)79.8 (alker )54.8 (AM. )17.7 (The lag time between)]TJ
2.175 -1.25 Td
[(onset of symptoms and diagnosis of rheumatoid arthritis. )54.9 (Arthritis)]TJ
T*
(Rheum 1994;37:814-20.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(24.)-875.1 (Bisgard KM, Folsom )54.8 (AR, Hong CP)110.7 (, Sellers )17.7 (T)79.7 (A. Mortality and)]TJ
0 Tc 2.175 -1.25 Td
(cancer rates in nonrespondents to a prospective cohort study of)Tj
-0.00011 Tc T*
[(older women: 5-year follow-up. )54.8 (Am J Epidemiol )]TJ
0 Tc 0 Tw T*
(1994;139:990-1000.)Tj
0.0249 Tw -2.175 -1.25 Td
[(25.)-875 (Ferraccioli GF)79.8 (, Cavalieri F)79.8 (, Mercadanti M, Conti G, )17.7 (V)60.1 (iviano P)110.8 (,)]TJ
-0.00011 Tc 2.175 -1.25 Td
(Ambanelli U. Clinical features, scintiscan characteristics and X-ray)Tj
0 Tc T*
(progression of late onset rheumatoid arthritis. Clin Exp Rheumatol)Tj
0 Tw T*
(1984;2:157-61.)Tj
0.02499 Tw -2.175 -1.25 Td
[(26.)-875 (Deal CL, Meenan RF)79.8 (, Goldenber)17.8 (g DL, et al. )17.8 (The clinical features)]TJ
-0.00011 Tc 2.175 -1.25 Td
[(of elderly-onset rheumatoid arthritis. )54.8 (A)-219.9 (comparison with )]TJ
T*
[(younger)19.7 (-onset disease of similar duration. )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(1985;28:987-94.)Tj
0.0249 Tw -2.175 -1.25 Td
[(27.)-875 (van der Heijde DM, van Riel PL, van Leeuwen MA, van\222)17.8 (t Hof MA,)]TJ
2.175 -1.25 Td
(van Rijswijk MH, van de Putte LB. Older versus younger onset)Tj
-0.00011 Tc T*
(rheumatoid arthritis: results at onset and after 2 years of a)Tj
0 Tc T*
(prospective followup study of early rheumatoid arthritis. )Tj
T*
(J Rheumatol 1991;18:1285-9.)Tj
-2.175 -1.25 Td
[(28.)-875 (Cerhan JR, )17.7 (W)79.8 (allace RB, Folsom )54.8 (AR, Potter JD, Munger RG,)]TJ
-0.00011 Tc 2.175 -1.25 Td
[(Prineas RJ. )17.7 (T)34.8 (ransfusion history and cancer risk in older women.)]TJ
0 Tc T*
[(Ann Intern Med 1993;1)36.9 (19:8-15.)]TJ
-2.175 -1.25 Td
[(29.)-875 (Blumber)17.8 (g N, Heal JM. )17.7 (The transfusion immunomodulation theory:)]TJ
2.175 -1.25 Td
[(the )17.8 (Th1/Th2 paradigm and an analogy with pregnancy as a unifying)]TJ
T*
(mechanism. Semin Hematol 1996;33:329-40.)Tj
-0.00011 Tc 0.00729 Tw -2.175 -1.25 Td
[(30.)-875.1 (Lapierre V)129.1 (,)-0.1 ( )37.1 (Auperin )37.1 (A, T)34.8 (iber)17.7 (ghien )-17.8 (P)110.7 (.)-0.1 ( T)34.8 (ransfusion-induced)]TJ
0 Tc 0.0249 Tw 2.175 -1.25 Td
[(immunomodulation following cancer sur)17.8 (gery: fact or fiction? J Natl)]TJ
T*
(Cancer Inst 1998;90:573-80.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(31.)-875.1 (Opelz G, )17.7 (T)69.7 (erasaki PI. Dominant ef)17.7 (fect of transfusions on kidney)]TJ
0 Tc 2.175 -1.25 Td
[(graft survival. )17.7 (T)34.9 (ransplantation 1980;29:153-8.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(32.)-875.1 (Stirrat GM. Pregnancy and immunity)64.8 (. BMJ 1994;308:1385-6.)]TJ
T*
[(33.)-875.1 (Peters )17.7 (WR, Fry RD, Fleshman JW)91.7 (, Kodner IJ. Multiple blood)]TJ
2.175 -1.25 Td
[(transfusions reduce the recurrence rate of Crohn\222)54.8 (s disease. Dis)]TJ
0 Tc T*
(Colon Rectum 1989;32:749-53.)Tj
-2.175 -1.25 Td
[(34.)-875 (Silvis R, Steup )17.7 (WH, Brand )54.8 (A, et al. Protective ef)17.8 (fect of blood)]TJ
-0.00011 Tc 2.175 -1.25 Td
[(transfusions on postoperative recurrence of Crohn\222)54.8 (s disease in)]TJ
T*
[(parous women. )17.7 (T)34.8 (r)-0.1 (ansfusion 1994;34:242-7.)]TJ
0 Tc 30.825 51.25 Td
[(35.)-875 (Lagaaij EL, Hennemann IP)110.8 (, Ruigrok M, et al. Ef)17.8 (fect of one-HLA-)]TJ
2.175 -1.25 Td
(DR-antigen-matched and completely HLA-DR-mismatched blood)Tj
-0.00011 Tc T*
(transfusions on survival of heart and kidney allografts. N Engl J)Tj
0 Tc T*
(Med 1989;321:701-5.)Tj
-2.175 -1.25 Td
[(36.)-875 (van Rood JJ, Claas FH. )17.7 (The influence of allogeneic cells on the)]TJ
2.175 -1.25 Td
[(human )17.8 (T)-257.2 (and B cell repertoire. Science 1990;248:1388-93.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(37.)-875.1 (Nelson JL, Hughes KA, Smith )54.8 (AG, Nisperos BB, Branchaud )54.8 (AM,)]TJ
2.175 -1.25 Td
[(Hansen JA. Maternal-fetal disparity in HLA)-220.2 (class II alloantigens)]TJ
0 Tc T*
(and the pregnancy-induced amelioration of rheumatoid arthritis. )Tj
T*
(N Engl J Med 1993;329:466-71.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(38.)-875.1 (van der Horst-Bruinsma IE, de )17.7 (V)60 (ries RR, de Buck PD, et al.)]TJ
0 Tc 2.175 -1.25 Td
(Influence of HLA-class II incompatibility between mother and)Tj
T*
(fetus on the development and course of rheumatoid arthritis of the)Tj
T*
[(mother)54.9 (. )54.9 (Ann Rheum Dis 1998;57:286-90.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(39.)-875.1 (van der Horst-Bruinsma IE, Huizinga )17.7 (TW)91.7 (, Lagaay EM, et al. )17.7 (The)]TJ
0 Tc 2.175 -1.25 Td
(influence of a partially HLA-matched blood transfusion on the)Tj
T*
(disease activity of rheumatoid arthritis. Rheumatology \(Oxford\))Tj
0 Tw T*
(1999;38:53-8.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(40.)-875.1 (Cauley JA, Gutai JP)110.7 (, Kuller LH, LeDonne D, Powell JG. )17.7 (The)]TJ
0 Tc 2.175 -1.25 Td
(epidemiology of serum sex hormones in postmenopausal women.)Tj
T*
[(Am J Epidemiol 1989;129:1)36.9 (120-31.)]TJ
-2.175 -1.25 Td
[(41.)-875 (V)111.1 (essey MP)110.8 (, )17.7 (V)60.1 (illard-Mackintosh L, )36.8 (Y)100.1 (eates D. Oral contraceptives,)]TJ
2.175 -1.25 Td
(cigarette smoking and other factors in relation to arthritis.)Tj
T*
(Contraception 1987;35:457-64.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(42.)-875.1 (Folsom )54.8 (AR, Kaye SA, Potter JD, Prineas RJ. )54.8 (Association of)]TJ
0 Tc 2.175 -1.25 Td
(incident carcinoma of the endometrium with body weight and fat)Tj
T*
[(distribution in older women: early findings of the Iowa )17.8 (W)79.8 (omen\222)54.9 (s)]TJ
T*
[(Health Study)64.9 (. Cancer Res 1989;49:6828-31.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(43.)-875.1 (Kaye SA, Folsom )54.8 (AR, Soler JT)73.9 (, Prineas RJ, Potter JD. )54.8 (Associations)]TJ
0 Tc 2.175 -1.25 Td
(of body mass and fat distribution with sex hormone concentrations)Tj
T*
(in postmenopausal women. Int J Epidemiol 1991;20:151-6.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(44.)-875.1 (Hazes JM, Dijkmans BA, )17.7 (V)111 (andenbroucke JP)110.7 (, de )17.7 (V)60 (ries RR, Cats )54.8 (A.)]TJ
0 Tc 2.175 -1.25 Td
(Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and)Tj
T*
[(alcohol consumption. )54.9 (Ann Rheum Dis 1990;49:980-2.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(45.)-875.1 (Ginsbur)17.7 (g ES. Estrogen, alcohol and breast cancer risk \(review\). )]TJ
0 Tc 2.175 -1.25 Td
(J Steroid Biochem Mol Biol 1999;69:299-306.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(46.)-875.1 (MacGregor RR. )54.8 (Alcohol and immune defense. JAMA)]TJ
0 Tc 0 Tw 2.175 -1.25 Td
(1986;256:1474-9.)Tj
0.0249 Tw -2.175 -1.25 Td
[(47.)-875 (Bounds )17.7 (W)91.8 (, Betzing KW)91.8 (, Stewart RM, Holcombe RF)79.8 (. Social)]TJ
2.175 -1.25 Td
(drinking and the immune response: impairment of )Tj
T*
[(lymphokine- activated killer activity)64.9 (. )54.8 (Am J Med Sci )]TJ
0 Tw T*
(1994;307:391-5.)Tj
ET
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_0 8 Tf
120.092 51 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2002. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_1 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
102 0 obj
<>
endobj
126 0 obj
<>
endobj
66 0 obj
<>
endobj
71 0 obj
<>
endobj
72 0 obj
<>
endobj
94 0 obj
<>stream
HtV
PT}owY_ *A+(`S++
F萠VORh&cLxQ5XZh&N2֎:vNc;~Xt̷{9} c54L-Xp_mNj4n <u_oo^z@fK_E
U_µ>ܓ[ZG*^35!LB[$[>{"UE uu'57R^lU?
zzpuA:J$i@E?qwAH
`Ǒ\ԛqf
?[b1y(>C
>䎥o!~/wNҖЂoF*P(Ն=Z{8gYHF:cVVd: